0.15Open0.15Pre Close0 Volume96 Open Interest12.50Strike Price0.00Turnover0.00%IV204.09%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.15Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma27.73Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Solid Biosciences Stock Discussion
RA capital and perspective advisors are both investors here. They also are invested in $Bright Minds Biosciences (DRUG.US)$
DRUG ran recently as we all know but also ran 3000% in 2022. Each time RA Capital and perspective advisors were invested and both times there were private placements after they ran.
In 2021 SLDB ran 450%, RA Capital and perspective advisors both invested and a private placement after it ran.
SLDB has not had a major run since but maybe it will a...
» Holdings in Top 20: 58.46%
» Qtr over Qtr Change**: 28.47%
Top Holdings:
$Cerevel Therapeutics Holdings (CERE.US)$
$Amicus Therapeutics (FOLD.US)$
$Iovance Biotherapeutics (IOVA.US)$
$Arcellx (ACLX.US)$
$Nuvalent (NUVL.US)$
$Apogee Therapeutics (APGE.US)$
$Inhibrx (INBX.US)$
$Fusion Pharmaceuticals (FUSN.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Vaxcyte (PCVX.US)$
$Soleno Therapeutics (SLNO.US)$
$Medtronic (MDT.US)$
$Madrigal Pharmaceuticals (MDGL.US)$